PKD2 was found to be capable to orchestrate cancer cell proliferation, survival, angiogenesis, motility and immune response by regulating multiple signaling pathways (e.g., MEK/ERK, NF-κB), as well as integrating extracellular signals (e.g., signals from hypoxia, growth factors)25,26. The gene discussed is PKD2; the disease is cancer.